Research on myostatin inhibitor ACE-031 stopped – but the stuff does work
Pharmaceutical companies Acceleron Pharma and Shire have put the myostatin inhibitor ACE-031 on hold. They made an announcement about this in a joint press release recently [acceleronpharma.com May 2, 2013]. A strange...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.